Pharma

Your Article Summary

See Latest Articles

Bristol-Myers Squibb Extends Tender Offer for Medarex, Inc.
Bristol Myers-Squibb Company, 08/21/09

Bristol–Myers Squibb Company announced that it has extended its previously announced cash tender offer, through its wholly–owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex on August 2009, unless further extended. The tender offer that was originally scheduled on August 2009 was extended, with the consent of Medarex, in connection with the parties reaching an agreement in principle to settle the legal proceedings pending in connection with the tender offer. All other terms and conditions of the tender offer remain unchanged.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

 See all of Regulatory Issues